Xuli Meng
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Extracellular vesicles in disease 4
- FOXO transcription factor regulation 3
- Oncology 22
- Cancer Cells and Metastasis 6
- Cancer Immunotherapy and Biomarkers 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- Qinghui Zheng (14 shared papers)Long Zhang (6 shared papers)Fangfang Zhou (6 shared papers)Heyu Li (3 shared papers)Hongchao Tang (13 shared papers)Bin Wang (1 shared paper)Mengdi Zhang (1 shared paper)Jie Qiu (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)World Journal of Surgical Oncology (2 papers)Advanced Science (2 papers)Frontiers in Oncology (2 papers)Experimental and Molecular Pathology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xuli Meng
41 papers receiving 785 citations
Xuli Meng's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 220
- Oncology 257
- Molecular Biology 489
- Immunology 128
- Biotechnology 36
Countries citing papers authored by Xuli Meng
This map shows the geographic impact of Xuli Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuli Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuli Meng more than expected).
Fields of papers citing papers by Xuli Meng
This network shows the impact of papers produced by Xuli Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuli Meng. The network helps show where Xuli Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuli Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy Hit paper breakdown → | 2023 | 129 |
| 2 | 2022 | 102 | |
| 3 | 2021 | 86 | |
| 4 | 2022 | 54 | |
| 5 | 2021 | 48 | |
| 6 | 2023 | 38 | |
| 7 | 2022 | 34 | |
| 8 | 2022 | 30 | |
| 9 | 2023 | 28 | |
| 10 | 2024 | 23 | |
| 11 | 2023 | 20 | |
| 12 | 2022 | 16 | |
| 13 | 2021 | 14 | |
| 14 | 2017 | 14 | |
| 15 | 2025 | 13 | |
| 16 | 2023 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2024 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2023 | 10 |
About Xuli Meng
Xuli Meng is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 43 papers that have together received 792 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Extracellular vesicles in disease (4 papers), Cancer Genomics and Diagnostics (3 papers), FOXO transcription factor regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (220 citations), Oncology (257 citations), Molecular Biology (489 citations), Immunology (128 citations) and Biotechnology (36 citations). Xuli Meng has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Qinghui Zheng, Long Zhang, Fangfang Zhou, Heyu Li, Hongchao Tang, Bin Wang, Mengdi Zhang, Jie Qiu, Peng Su and Feng Xie. Their work appears in journals such as Frontiers in Immunology, World Journal of Surgical Oncology, Advanced Science, Frontiers in Oncology and Experimental and Molecular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.